Bacteriophages for the Treatment of Graft Infections in Cardiovascular Medicine
| العنوان: | Bacteriophages for the Treatment of Graft Infections in Cardiovascular Medicine |
|---|---|
| المؤلفون: | Juliane Kohlen, Sebastian V. Rojas, Justus Gross, Romy Skusa, Jan Gummert, Eberhard Grambow, Simon Junghans, Anja Püschel, Philipp Warnke |
| المصدر: | Antibiotics, Vol 10, Iss 1446, p 1446 (2021) Antibiotics |
| بيانات النشر: | MDPI AG, 2021. |
| سنة النشر: | 2021 |
| مصطلحات موضوعية: | Microbiology (medical), medicine.medical_specialty, Phage therapy, medicine.drug_class, medicine.medical_treatment, Antibiotics, Context (language use), Review, RM1-950, Biochemistry, Microbiology, Bacteriophage, Antibiotic resistance, bacteriophage, medicine, phage, Pharmacology (medical), antimicrobial resistance, General Pharmacology, Toxicology and Pharmaceutics, Intensive care medicine, biology, business.industry, vascular graft, Immunosuppression, biology.organism_classification, infection, Infectious Diseases, Personalized medicine, Therapeutics. Pharmacology, prosthesis, business, Vascular graft |
| الوصف: | Bacterial infections of vascular grafts represent a major burden in cardiovascular medicine, which is related to an increase in morbidity and mortality. Different factors that are associated with this medical field such as patient frailty, biofilm formation, or immunosuppression negatively influence antibiotic treatment, inhibiting therapy success. Thus, further treatment strategies are required. Bacteriophage antibacterial properties were discovered 100 years ago, but the focus on antibiotics in Western medicine since the mid-20th century slowed the further development of bacteriophage therapy. Therefore, the experience and knowledge gained until then in bacteriophage mechanisms of action, handling, clinical uses, and limitations were largely lost. However, the parallel emergence of antimicrobial resistance and individualized medicine has provoked a radical reassessment of this approach and cardiovascular surgery is one area in which phages may play an important role to cope with this new scenario. In this context, bacteriophages might be applicable for both prophylactic and therapeutic use, serving as a stand-alone therapy or in combination with antibiotics. From another perspective, standardization of phage application is also required. The ideal surgical bacteriophage application method should be less invasive, enabling highly localized concentrations, and limiting bacteriophage distribution to the infection site during a prolonged time lapse. This review describes the latest reports of phage therapy in cardiovascular surgery and discusses options for their use in implant and vascular graft infections. |
| اللغة: | English |
| تدمد: | 2079-6382 |
| URL الوصول: | https://explore.openaire.eu/search/publication?articleId=doi_dedup___::420649433d068c1a01e92efc376eed67 https://www.mdpi.com/2079-6382/10/12/1446 |
| حقوق: | OPEN |
| رقم الأكسشن: | edsair.doi.dedup.....420649433d068c1a01e92efc376eed67 |
| قاعدة البيانات: | OpenAIRE |
| تدمد: | 20796382 |
|---|